Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) VP Ganesh Venkataraman Kaundinya sold 1,050 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $10.18, for a total value of $10,689.00. SleekMoney, 1 day ago
Ganesh Venkataraman Kaundinya Sells 1,050 Shares of Momenta Pharmaceuticals, Inc. (MNTA) Stock - Ticker Report, 2 days ago
Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001179110-16-023095 Filing Date 2016-04-15 2016-04-15 13:45:30 Period of Report 2016-04-13 Filing Date Changed 2016-04-15 Document Format Files ...SEC Filings, 1 month ago
WASHINGTON, D.C. — So far, seven Indian American youths who are exceptional at spelling and have gone on the win the title of regional champions in their home states will be heading for this year's annual Scripps National Spelling Bee , set to be ...India-West, 4 weeks ago
The moment Saradha-tainted Madan Mitra was renominated as a Trinamool Congress (TMC) candidate by West Bengal Chief Minister and party supremo Mamata Banerjee, the former transport minister's family wasted no time and rushed to a nondescript temple ...New Indian Express, 1 month ago
The FDA just approved a version of Remicade, a drug used to treat autoimmune diseases like Crohn's disease and rheumatoid arthritis. The drug, which was developed by Celltrion and will be co-marketed by Pfizer, goes by the name Inflectra. It's a ...AOL.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!